Navigation Links
Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
Date:5/23/2011

d John C. Lechleiter, Ph.D., Lilly president, chairman and chief executive officer. "We are confident that BioCritica will help realize the full potential for Xigris, while working to develop new critical care medicines. We look forward to working with BioCritica to help ensure its success."

"For severe sepsis patients, Xigris is an important life-saving drug," said David Broecker, chief executive officer of BioCritica.  "Each year more than 200,000 people die from severe sepsis in the U.S. We look forward to building a company dedicated to saving lives.  We also appreciate the support of Lilly, the IEDC, and BioCrossroads in helping us get established here in Indiana."

"Indiana's consistently strong growth in the life sciences sector is evidence that not only do we have the talent to power some of the world's top biotechnology companies, but we also have an environment welcoming to the kind of noticeable impact companies like BioCritica and others will have on our state's economy and the quality of life of citizens everywhere," said Mitch Roob, Indiana Secretary of Commerce and chief executive officer of the Indiana Economic Development Corporation.  

IMPORTANT SAFETY INFORMATION

About Xigris® (drotrecogin alfa (activated))

Injection, Powder, Lyophilized, For Solution for Intravenous

5 mg and 20 mg vials

Indications:

Xigris is indicated for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have a high risk of death (e.g., as determined by APACHE II score greater than or equal to 25*).

Limitations of Use:

Xigris is not indicated in adult patients with severe sepsis and lower risk of death. (e.g., APACHE II score <25).

Xigris is not indicated in pediatric patients.  

CONTRAINDICATIONS

Xigris increases the risk of bleeding. Xigris is
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
2. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
3. Lilly Provides Its Perspective in Response to Amylin Lawsuit
4. Lilly Provides Statement in Response to Amylin Lawsuit
5. Lilly USA, LLC Launches TruAssist for Patients
6. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
7. Lilly Oncology to Present New Data on Nine of Its Pipeline Molecules at ASCO 2011
8. Amylin Pharmaceuticals Files Suit Against Eli Lilly
9. Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trusts Grow What Works Campaign
10. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
11. Lilly and Medtronic Announce Drug-Device Collaboration for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. (NASDAQ: ... cancer screening study i published on-line this ... journal of the American Cancer Society. ... the University of Pittsburgh Medical Center, supports current consensus guidelines ... that women 30-65 years of age be co-tested ...
(Date:4/16/2015)... April 16, 2015 Mallinckrodt plc (NYSE: ... today announced that it has completed its acquisition ... approximately $2.3 billion. The Ikaria acquisition extends Mallinckrodt,s ... reach into neonatal critical care with INOMAX ® ... for a highly vulnerable patient population. It also ...
(Date:4/16/2015)... , April 16, 2015  Rosewind Corporation (OTCMKTS: ... reverse merger with a newly formed specialty healthcare ... focus on addressing urological disorders. The merged company, ... Inc., has commenced operations and incorporates the pipeline ... The Company,s strategy is to build a late-stage ...
Breaking Medicine Technology:Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Fla., May 26, 2011 Tigris Pharmaceuticals, Inc., today ... Phase 2 clinical trial of AFP-464 (aminoflavone prodrug) with ... cancer patients. Molecular profiling will be used to pre-screen ... which has shown to predict sensitivity to ...
... 26, 2011 Medical Affairs serves as the linchpin for ... a successful market entry of a new product. ... trial strategy & planning, and publication strategy & planning, are ... the activities where organizations turn to Medical Affairs to play ...
Cached Medicine Technology:Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 2Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 3Medical Affairs Role in New Product Planning Detailed in Best Practices, LLC Report 2
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a turbulent world, people may find themselves in dangerous situations ... first move, but some situations can be avoided if there ...
(Date:4/17/2015)... Rosetta Radiology is proud to now offer ... of diagnostic imaging services. This solidifies them as a ... East Side of Manhattan. , The new imaging equipment ... of PET-CT, combined with Rosetta’s state of the art ... with patients through several stages of the cancer care ...
(Date:4/17/2015)... have seen healing, a lot of healing, and a lot ... Kafader of Friendship Village. “People have found purpose. ... have created beautiful pieces of art.” For the past eight ... was launched to benefit residents of the retirement community. , ... Institute in Chicago, worked as an intern at Friendship Village, ...
(Date:4/17/2015)... Rapids, MI (PRWEB) April 17, 2015 Enthusiasts ... CRUSH Grand Rapids, Saturday, April 25, 2015. The event will ... Reserve Wine & Food (201 Monroe Ave NW, Grand Rapids, ... from around the West Michigan area. Patrons are encouraged to ... of elegance and fun. , This year’s event will feature ...
(Date:4/17/2015)... Baptist Health and The University of Texas ... designed to transform oncology care in northeast Florida and ... create a joint cancer program to enhance patient access ... MD Anderson Cancer Center is anticipated to open in ... highly coordinated, multidisciplinary cancer care for adults in the ...
Breaking Medicine News(10 mins):Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3
... up nationwide installation service for its smartTOUCH(R),product line, ... (OTC,Bulletin Board: BMRX) today announced that it has ... national handyman service, Mr.,Handyman, to provide its customers ... products that,include garage door openers, door locks, thermostats, ...
... Non-systemic and Non-invasive Treatment Cleared for,Patients Who Have ... Pa., Oct. 8 Neuronetics, Inc., a,privately-held medical ... of,neuromodulation, announced today that the U.S. Food and ... Magnetic Stimulation),Therapy system for the treatment of depression. ...
... 8 ILC Dover (http://www.ilcdover.com ),the company ... a premium line of aesthetically pleasing head covers ... product is the direct result,of feedback from healthcare ... less intimidating and more "patient friendly"., (Photo: ...
... ,Tis the season to be jolly, but all,the money ... have you,feeling less than merry. Don,t let yourself fall ... sense of obligation. Take the following,simple measures to prevent ... Family Therapists (CAMFT) http://www.camft.org :, -- Make ...
... Canadian Annual Meeting (November 5-7; Ottawa, Ontario, Canada) to ... the pharmaceutical industry, health academia, and the health care ... ... Horsham, PA (PRWEB) October 8, 2008 -- The http://www.diahome.org/ ...
... extension of its existing strategic alliance with Nano-Terra, Inc., a leading ... ... Wire EON) October 7, 2008 -- The original agreement between ... products and solutions based on Merck,s materials. , , , After ...
Cached Medicine News:Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5Health News:ILC Dover Introduces 'Patient Friendly' Respiratory Protection for Health Care Market 2Health News:Holiday Gift Giving: How You and Your Budget can Survive the Season 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: